一个老年女性患有 Amyloidosis 脏粉症的患者的复发性多流液
Ajith S Bharadwaj1, Karson Munson2, Moneeb Mustafa3,4,1
1Internal Medicine, Edward Via College of Osteopathic Medicine, Alexandria, USA.
Cureus
|October 29, 2025
概括
系统性amyloidosis是一种罕见的疾病,可能会导致难以诊断的症状,如由于液体积聚而导致的呼吸短促等. 这一案例突出显示,多流液是一种罕见的并发症,可以通过透析和利尿剂来治疗.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 在瘤学瘤学.
背景情况:
- 氨基粉症是一种罕见的全身性疾病,影响多个器官,包括脏,心脏和肺.
- 它的多样化呈现模仿其他疾病,导致诊断挑战和潜在的多器官功能障碍.
- 胸腔溢液是全身性粉样化症的一个罕见且不太了解的并发症.
研究的目的:
- 介绍一个患有粉样性病的老年女性的病例,她经历了反复出现的多发性液.
- 在全身性氨基粉症的背景下,探索多流的病理生理学.
- 讨论这种罕见并发症的诊断和管理策略.
主要方法:
- 一个有粉样性病史的老年女性患者的病例报告.
- 临床评估包括心脏和脏系统的评估,排除恶性瘤.
- 治疗包括透析,循环利尿剂用于液体过载,以及胸腔喷液的胸腔喷液.
主要成果:
- 由于大量的肺部液体积聚,患者出现了呼吸短促.
- 怀疑由粉样纤维素和功能衰竭引起的流体过载直接膜透是原因.
- 管理导致了患者病情的改善.
结论:
- 胸腔溢液可能是全身性粉症的罕见表现,可能是由直接粉样蛋白透和流体过载引起的.
- 多学科管理,包括解决功能衰竭和流体过载,至关重要.
- 需要进一步了解与粉样症相关的多流的病理生理学和治疗选择.
相关概念视频
Pleural Effusion I: Introduction
3.9K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
3.9K
Pleural Effusion II: Symptoms and Management
642
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
642
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
513
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
513
Chronic Kidney Disease II: Clinical Manifestations
543
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
543
Nephrotic Syndrome III : Nursing Management
277
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
277
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
232
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
232


